// App-Quantinova.ai

SAT0229 : PROTEOMIC ANALYSIS REVEALS ASSOCIATION BETWEEN IMMUNE-METABOLIC BIOMARKERS AND CLINICAL SYMPTOMS IN SICCA PATIENTS

Researchers

Presenter

  • V. Pucino

Principal Investigators

  • J. D. Turner

  • F. Kollert

  • S. Rauz

  • A. Richard

  • J. Higham

  • A. Poveda-Gallego

  • S. J. Bowman

  • F. Barone

  • B. Fisher

Medical Centers

  • Institute of Inflammation and Ageing College of Medical and Dental Sciences University of Birmingham, Birmingham, United Kingdom

  • National Institute for Health Research (NIHR), Birmingham Biomedical Research Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Department of Rheumatology, Immunology, and Allergology, Inselspital, University Hospital Bern, Bern, Switzerland, Bern, Switzerland

  • Academic Unit of Ophthalmology, Birmingham and Midland Eye Centre, Birmingham, UK, Birmingham, United Kingdom

  • Dept of Oral Medicine, Birmingham Dental Hospital, Birmingham, United Kingdom

Locations

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

  • Autoimmune (AI)

Disease

  • Sjogren's syndrome

  • Dry Eye Syndrome

Biomarkers

  • Body mass index

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved